BRAF mutation status and its prognostic significance in 79 canine urothelial carcinomas: A retrospective study (2006–2019)

米托蒽醌 医学 内科学 回顾性队列研究 肿瘤科 美洛昔康 泌尿科 胃肠病学 多元分析 化疗
作者
Julia Gedon,Alexandra Kehl,Heike Aupperle‐Lellbach,Wolf von Bomhard,Jarno M. Schmidt
出处
期刊:Veterinary and Comparative Oncology [Wiley]
卷期号:20 (2): 449-457 被引量:19
标识
DOI:10.1111/vco.12790
摘要

Urothelial carcinoma (UC) is the most common tumour of the canine urinary bladder. Recently, BRAF mutation testing emerged as a diagnostic option, but its prognostic significance is unknown. This study investigates the relationship between BRAF (variant V595E) mutation status and overall survival in UC-bearing dogs. Seventy-nine patients histologically diagnosed with UC of the bladder and/or urethra between 2006 and 2019 were included in this retrospective single-centre-study. Treatment consisted of meloxicam (n = 39, group 1 'Melox'), mitoxantrone and meloxicam (+/- followed by metronomic chlorambucil; n = 23, group 2 'Chemo') or partial cystectomy followed by meloxicam +/- mitoxantrone (n = 17, group 3 'Sx'). Survival was significantly influenced by treatment (p = .0002) and tumour location (p < .001) in both uni- and multivariable analyses. BRAF mutation was identified in 51 tumours (=64.6%) and had no statistically significant influence on overall survival: MST for BRAF-negative patients 359 versus 214 days for BRAF-positive dogs (p = .055). However, in BRAF-positive dogs, survival depended significantly on type of treatment in univariable analysis: MSTs for groups 1-3 were 151, 244 and 853 days, respectively (p = .006); In BRAF-positive group 2 ('Chemo')-patients, adjuvant metronomic chlorambucil after mitoxantrone more than doubled MST compared to patients receiving mitoxantrone alone (588 vs. 216 days; p = .030). In contrast, MSTs were not significantly different in BRAF-negative patients among the three treatment groups (p = .069). Multivariate analysis of these data was not possible due to group size limitations. This study identified tumour location and treatment type, but not BRAF mutation status, as independent prognostic factors for overall survival.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
刚刚
刚刚
1秒前
龙虾完成签到,获得积分10
1秒前
张zh发布了新的文献求助10
1秒前
hyh完成签到,获得积分10
2秒前
Zzzzxs的应助被扬帆起航行万里采纳,获得10
2秒前
自觉的翼发布了新的文献求助10
2秒前
蜜汁章鱼丸完成签到 ,获得积分10
2秒前
2秒前
xiaoling发布了新的文献求助10
2秒前
xanthine完成签到,获得积分10
3秒前
3秒前
深情安青的应助被短耳鸮采纳,获得10
3秒前
林先生完成签到,获得积分10
3秒前
大饿鱼发布了新的文献求助10
4秒前
anyu完成签到,获得积分10
4秒前
4秒前
小米椒完成签到,获得积分10
5秒前
5秒前
Hello的应助被取名字好难采纳,获得10
5秒前
负责的菠萝完成签到,获得积分10
5秒前
jingluo完成签到,获得积分10
6秒前
7秒前
7秒前
优雅的香发布了新的文献求助10
7秒前
赘婿的应助被木木采纳,获得10
8秒前
Holand发布了新的文献求助10
8秒前
NexusExplorer的应助被jiangjiang采纳,获得10
8秒前
9秒前
tammy完成签到,获得积分10
10秒前
Diana发布了新的文献求助10
10秒前
研友_VZG7GZ的应助被独特的斑马采纳,获得10
11秒前
XL完成签到,获得积分10
11秒前
温暖的树叶完成签到,获得积分10
11秒前
12秒前
小彦发布了新的文献求助10
12秒前
wang完成签到,获得积分10
13秒前
13秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
Monte Cassino in the Middle Ages Volume I 310
JUSTIFICATION OF SMALL-SCALE MODELS: AN INDUSTRY PERSPECTIVE 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8156452
求助须知:如何正确求助?哪些是违规求助? 9552594
关于积分的说明 21710302
捐赠科研通 7745468
什么是DOI,文献DOI怎么找? 3426553
关于科研通互助平台的介绍 2551389
邀请新用户注册赠送积分活动 2470292